On August 17, NEJM Resident 360 will move to a new platform. Please note that we are temporarily suspending new account creation from Thursday, August 11, at 12 PM ET, until the site is live on August 17. Existing members will be sent an email with instructions for accessing their account on the new platform.* We look forward to sharing a fresh new look, easier navigation, and improved organization.
*If you currently sign in using Facebook or Twitter, you may need to create a new account after August 17.
Takehiko Sakai, MR
Visitor scientist at Dana-Farber Cancer Institute, Harvard Medical School
Dana-Farber Cancer Institute, Harvard Medical School